iSCAN: An RT-LAMP-coupled CRISPR-Cas12 module for rapid, sensitive detection of SARS-CoV-2
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
The COVID-19 pandemic caused by SARS-CoV-2 affects all aspects of human life. Detection platforms that are efficient, rapid, accurate, specific, sensitive, and user friendly are urgently needed to manage and control the spread of SARS-CoV-2. RT-qPCR based methods are the gold standard for SARS-CoV-2 detection. However, these methods require trained personnel, sophisticated infrastructure, and a long turnaround time, thereby limiting their usefulness. Reverse transcription-loop-mediated isothermal amplification (RT-LAMP), a one-step nucleic acid amplification method conducted at a single temperature, has been used for colorimetric virus detection. CRISPR-Cas12 and CRISPR-Cas13 systems, which possess collateral activity against ssDNA and RNA, respectively, have also been harnessed for virus detection. Here, we built an efficient, rapid, specific, sensitive, user-friendly SARS-CoV-2 detection module that combines the robust virus amplification of RT-LAMP with the specific detection ability of SARS-CoV-2 by CRISPR-Cas12. Furthermore, we combined the RT-LAMP-CRISPR-Cas12 module with lateral flow cells to enable highly efficient point-of-care SARS-CoV-2 detection. Our iSCAN SARS-CoV-2 detection module, which exhibits the critical features of a robust molecular diagnostic device, should facilitate the effective management and control of COVID-19.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884 · cited 1×
“Introduction In late 2019, an outbreak of the novel Severe acute respiratory syndrome-related coronavirus SARS-CoV-2, the causative agent of COVID-19, began in Wuhan, China and rapidly spread throughout the world [1-3].”
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575
Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30251-8 · Cited by 11,907
A new coronavirus associated with human respiratory disease in China
Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Song, Z.-G., Hu, Y., Tao, Z.-W., Tian, J.-H., Pei, Y.-Y., et al. (2020) · Nature · doi:10.1038/s41586-020-2008-3 · Cited by 11,688
Loop-mediated isothermal amplification of DNA
Notomi, T. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.12.e63 · Cited by 8,805 · cited 2×
“LAMP reactions employ DNA polymerases that possess strand-displacement activities, such as the Bst DNA polymerase large fragment, for efficient amplification of the target DNA [21].”
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
Corman, V. M., Landt, O., Kaiser, M., Molenkamp, R., Meijer, A., Chu, D. K., Bleicker, T., Brünink, S., Schneider, J., Schmidt, M. L., et al. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.3.2000045 · Cited by 7,344
The new frontier of genome engineering with CRISPR-Cas9
Doudna, J. A., & Charpentier, E. (2014) · Science · doi:10.1126/science.1258096 · Cited by 7,062 · cited 1×
“These systems have been used to engineer the genomes and transcriptomes of all transformable species (Mahas et al., 2019; Doudna and Charpentier, 2014; Mahas et al., 2017).”
MethodOrigin and evolution of pathogenic coronaviruses
Cui, J., Li, F., & Shi, Z.-L. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0118-9 · Cited by 5,515
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
Chen, J. S., Ma, E., Harrington, L. B., Da Costa, M., Tian, X., Palefsky, J. M., & Doudna, J. A. (2018) · Science · doi:10.1126/science.aar6245 · Cited by 4,507 · cited 3×
“For example, SHERLOCK (Specific High-sensitivity Enzymatic Reporter UnLOCKing) and DETECTR (DNA Endonuclease-Targeted CRISPR Trans Reporter) detection have attracted substantial attention [30, 34].”
Chan, J. F.-W., Kok, K.-H., Zhu, Z., Chu, H., To, K. K.-W., Yuan, S., & Yuen, K.-Y. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1719902 · Cited by 3,059
CRISPR–Cas12-based detection of SARS-CoV-2
Broughton, J. P., Deng, X., Yu, G., Fasching, C. L., Servellita, V., Singh, J., Miao, X., Streithorst, J. A., Granados, A., Sotomayor-Gonzalez, A., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0513-4 · Cited by 2,717
C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector
Abudayyeh, O. O., Gootenberg, J. S., Konermann, S., Joung, J., Slaymaker, I. M., Cox, D. B. T., Shmakov, S., Makarova, K. S., Semenova, E., Minakhin, L., et al. (2016) · Science · doi:10.1126/science.aaf5573 · Cited by 2,336
The Architecture of SARS-CoV-2 Transcriptome
Kim, D., Lee, J.-Y., Yang, J.-S., Kim, J. W., Kim, V. N., & Chang, H. (2020) · Cell · doi:10.1016/j.cell.2020.04.011 · Cited by 2,123
SHERLOCK: nucleic acid detection with CRISPR nucleases
Kellner, M. J., Koob, J. G., Gootenberg, J. S., Abudayyeh, O. O., & Zhang, F. (2019) · Nature Protocols · doi:10.1038/s41596-019-0210-2 · Cited by 1,631
CRISPR-Cas12a-assisted nucleic acid detection
Li, S.-Y., Cheng, Q.-X., Wang, J.-M., Li, X.-Y., Zhang, Z.-L., Gao, S., Cao, R.-B., Zhao, G.-P., & Wang, J. (2018) · Cell Discovery · doi:10.1038/s41421-018-0028-z · Cited by 1,530
Programmed DNA destruction by miniature CRISPR-Cas14 enzymes
Harrington, L. B., Burstein, D., Chen, J. S., Paez-Espino, D., Ma, E., Witte, I. P., Cofsky, J. C., Kyrpides, N. C., Banfield, J. F., & Doudna, J. A. (2018) · Science · doi:10.1126/science.aav4294 · Cited by 1,247
Discovery and Functional Characterization of Diverse Class 2 CRISPR-Cas Systems
Shmakov, S., Abudayyeh, O. O., Makarova, K. S., Wolf, Y. I., Gootenberg, J. S., Semenova, E., Minakhin, L., Joung, J., Konermann, S., Severinov, K., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.10.008 · Cited by 1,209
Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2
Wyllie, A. L., Fournier, J., Casanovas-Massana, A., Campbell, M., Tokuyama, M., Vijayakumar, P., Warren, J. L., Geng, B., Muenker, M. C., Moore, A. J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2016359 · Cited by 1,169
Diagnostics for the developing world
Mabey, D., Peeling, R. W., Ustianowski, A., & Perkins, M. D. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro841 · Cited by 1,054
Mori, Y., & Notomi, T. (2009) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-009-0669-9 · Cited by 1,015
CRISPR/Cas Systems towards Next-Generation Biosensing
Li, Y., Li, S., Wang, J., & Liu, G. (2019) · Trends in Biotechnology · doi:10.1016/j.tibtech.2018.12.005 · Cited by 917
Point-of-care nucleic acid testing for infectious diseases
Niemz, A., Ferguson, T. M., & Boyle, D. S. (2011) · Trends in Biotechnology · doi:10.1016/j.tibtech.2011.01.007 · Cited by 838
CRISPR-Cas Systems: Prokaryotes Upgrade to Adaptive Immunity
Barrangou, R., & Marraffini, L. A. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.03.011 · Cited by 832
Li, L., Li, S., Wu, N., Wu, J., Wang, G., Zhao, G., & Wang, J. (2019) · ACS Synthetic Biology · doi:10.1021/acssynbio.9b00209 · Cited by 793
Lu, X., Wang, L., Sakthivel, S. K., Whitaker, B., Murray, J., Kamili, S., Lynch, B., Malapati, L., Burke, S. A., Harcourt, J., et al. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2608.201246 · Cited by 676
CRISPR-mediated adaptive immune systems in bacteria and archaea
Sorek, R., Lawrence, C. M., & Wiedenheft, B. (2013) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-072911-172315 · Cited by 668
Cas12aVDet: A CRISPR/Cas12a-Based Platform for Rapid and Visual Nucleic Acid Detection
Wang, B., Wang, R., Wang, D., Wu, J., Li, J., Wang, J., Liu, H., & Wang, Y. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b01526 · Cited by 440
Nucleic Acid Detection Using CRISPR/Cas Biosensing Technologies
Aman, R., Mahas, A., & Mahfouz, M. (2020) · ACS Synthetic Biology · doi:10.1021/acssynbio.9b00507 · Cited by 409
Self-citationHan, Y., & Yang, H. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25749 · Cited by 390
Rapid Molecular Detection of SARS-CoV-2 (COVID-19) Virus RNA Using Colorimetric LAMP
Zhang, Y., Odiwuor, N., Xiong, J., Sun, L., Nyaruaba, R. O., Wei, H., & Tanner, N. A. (2020) · medRxiv · doi:10.1101/2020.02.26.20028373 · Cited by 355
Point-of-care testing for COVID-19 using SHERLOCK diagnostics
Joung, J., Ladha, A., Saito, M., Segel, M., Bruneau, R., Huang, M.-L. W., Kim, N.-G., Yu, X., Li, J., Walker, B. D., et al. (2020) · doi:10.1101/2020.05.04.20091231 · Cited by 317
Nguyen, T., Duong Bang, D., & Wolff, A. (2020) · Micromachines · doi:10.3390/mi11030306 · Cited by 291
Repurposing CRISPR-Cas12b for mammalian genome engineering
Teng, F., Cui, T., Feng, G., Guo, L., Xu, K., Gao, Q., Li, T., Li, J., Zhou, Q., & Li, W. (2018) · Cell Discovery · doi:10.1038/s41421-018-0069-3 · Cited by 261
Wang, Y., Ke, Y., Liu, W., Sun, Y., & Ding, X. (2020) · ACS Sensors · doi:10.1021/acssensors.0c00320 · Cited by 192
CRISPR-Cas13d mediates robust RNA virus interference in plants
Mahas, A., Aman, R., & Mahfouz, M. (2019) · Genome Biology · doi:10.1186/s13059-019-1881-2 · Cited by 188
Self-citationRapid point-of-care testing for SARS-CoV-2 in a community screening setting shows low sensitivity
Döhla, M., Boesecke, C., Schulte, B., Diegmann, C., Sib, E., Richter, E., Eschbach-Bludau, M., Aldabbagh, S., Marx, B., Eis-Hübinger, A.-M., et al. (2020) · Public Health · doi:10.1016/j.puhe.2020.04.009 · Cited by 176
Full-Genome Deep Sequencing and Phylogenetic Analysis of Novel Human Betacoronavirus
Cotten, M., Lam, T. T., Watson, S. J., Palser, A. L., Petrova, V., Grant, P., Pybus, O. G., Rambaut, A., Guan, Y., Pillay, D., et al. (2013) · Emerging Infectious Diseases · doi:10.3201/eid1905.130057 · Cited by 150
Synthetic evolutionary origin of a proofreading reverse transcriptase
Ellefson, J. W., Gollihar, J., Shroff, R., Shivram, H., Iyer, V. R., & Ellington, A. D. (2016) · Science · doi:10.1126/science.aaf5409 · Cited by 141
Harnessing CRISPR/Cas systems for programmable transcriptional and post-transcriptional regulation
Mahas, A., Neal Stewart, C., & Mahfouz, M. M. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2017.11.008 · Cited by 110
Self-citationNagai, K., Horita, N., Yamamoto, M., Tsukahara, T., Nagakura, H., Tashiro, K., Shibata, Y., Watanabe, H., Nakashima, K., Ushio, R., et al. (2016) · Scientific Reports · doi:10.1038/srep39090 · Cited by 95
Chou, P.-H., Lin, Y.-C., Teng, P., Chen, C.-L., & Lee, P.-Y. (2011) · Journal of Virological Methods · doi:10.1016/j.jviromet.2011.01.009 · Cited by 91
Molecular methods used in clinical laboratory: prospects and pitfalls
Morshed, M. G., Lee, M.-K., Jorgensen, D. R., & Isaac‐Renton, J. L. (2007) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2006.00191.x · Cited by 53
Ma, Y., Zhang, B., Wang, M., Ou, Y., Wang, J., & Li, S. (2016) · BioMed Research International · doi:10.1155/2016/2906484 · Cited by 36
Jones, G., Hello, S. L., Silva, N. J., Vaillant, V., de Valk, H., Weill, F., & Strat, Y. L. (2014) · Eurosurveillance · doi:10.2807/1560-7917.es2014.19.1.20664 · Cited by 25
Cited by
Safiabadi Tali, S. H., LeBlanc, J. J., Sadiq, Z., Oyewunmi, O. D., Camargo, C., Nikpour, B., Armanfard, N., Sagan, S. M., & Jahanshahi-Anbuhi, S. (2021) · Clinical Microbiology Reviews · doi:10.1128/cmr.00228-20 · Cited by 405
de Puig, H., Lee, R. A., Najjar, D., Tan, X., Soenksen, L. R., Angenent-Mari, N. M., Donghia, N. M., Weckman, N. E., Ory, A., Ng, C. F., et al. (2021) · Science Advances · doi:10.1126/sciadv.abh2944 · Cited by 325
Lateral flow test engineering and lessons learned from COVID-19
Budd, J., Miller, B. S., Weckman, N. E., Cherkaoui, D., Huang, D., Decruz, A. T., Fongwen, N., Han, G.-R., Broto, M., Estcourt, C. S., et al. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-022-00007-3 · Cited by 308
CRISPR-Cas based virus detection: Recent advances and perspectives
Yin, L., Man, S., Ye, S., Liu, G., & Ma, L. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2021.113541 · Cited by 277
Point-of-care COVID-19 diagnostics powered by lateral flow assay
Zhou, Y., Wu, Y., Ding, L., Huang, X., & Xiong, Y. (2021) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2021.116452 · Cited by 180
Metadata
- Authors
- Ali, Z., Aman, R., Mahas, A., Rao, G. S., Tehseen, M., Marsic, T., Salunke, R., Subudhi, A. K., Hala, S. M., Hamdan, S. M., Pain, A., Alofi, F. S., Alsomali, A., Hashem, A. M., Khogeer, A., Almontashiri, N. A. M., Abedalthagafi, M., Hassan, N., & Mahfouz, M. M.
- Venue
- Virus Research
- Publisher
- Elsevier BV
- Published
- 2020-10
- Volume
- 288
- Pages
- 198129
- ISSN
- 0168-1702 (ISSN-L)
- OpenAlex
- W3060075221
- Cited by
- 310
- References
- 46
- FWCI
- 6.52
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.